Cargando…
Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
BACKGROUND: Recent in vitro and animal experiments suggest that peroxisome proliferation-activated receptor gamma (PPARɣ) agonist medications, such as antidiabetic glitazone (GTZ) drugs, are neuroprotective in models of Parkinson’s disease (PD). These findings have not been tested in humans. We hypo...
Autores principales: | Brauer, Ruth, Bhaskaran, Krishnan, Chaturvedi, Nishi, Dexter, David T., Smeeth, Liam, Douglas, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511413/ https://www.ncbi.nlm.nih.gov/pubmed/26196151 http://dx.doi.org/10.1371/journal.pmed.1001854 |
Ejemplares similares
-
Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014
por: Mathur, Rohini, et al.
Publicado: (2017) -
Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006–2019: A cohort study
por: Eastwood, Sophie V., et al.
Publicado: (2021) -
Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
por: Douglas, Ian J, et al.
Publicado: (2013) -
Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017) -
Ethnic differences in hypertension management, medication use and blood pressure control in UK primary care, 2006–2019: a retrospective cohort study
por: Eastwood, Sophie V., et al.
Publicado: (2022)